Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Intracranial hemorrhage during GliaSite RTS manipulation in an anticoagulated patient.

Gerber DE, Grossman SA, Chan TA, Kleinberg L.

J Radiother Pract. 2007;6:53-57.

2.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
3.

An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.

Tatter SB, Shaw EG, Rosenblum ML, Karvelis KC, Kleinberg L, Weingart J, Olson JJ, Crocker IR, Brem S, Pearlman JL, Fisher JD, Carson K, Grossman SA; New Approaches to Brain Tumor Therapy Central Nervous System Consortium..

J Neurosurg. 2003 Aug;99(2):297-303.

PMID:
12924704
4.

Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.

Gobitti C, Borsatti E, Arcicasa M, Roncadin M, Franchin G, Minatel E, Skrap M, Zanotti B, Tuniz F, Cimitan M, Capra E, Drigo A, Trovò MG.

Tumori. 2011 Sep-Oct;97(5):614-9. doi: 10.1700/989.10721.

5.

The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.

Wernicke AG, Sherr DL, Schwartz TH, Pannullo SC, Stieg PE, Boockvar JA, Moliterno JA, Ivanidze J, Trichter S, Sabbas AM, Parashar B, Nori D.

Brachytherapy. 2010 Jan-Mar;9(1):91-9. doi: 10.1016/j.brachy.2009.06.005. Epub 2009 Oct 21.

PMID:
19850535
6.

GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.

Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, Bastin KT, Watson G, Burri S, Stea B.

Neurosurgery. 2006 Apr;58(4):701-9; discussion 701-9. Erratum in: Neurosurgery. 2006 Oct;59(4):821.

PMID:
16575334
7.

Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection.

Wernicke AG, Sherr DL, Schwartz TH, Pannullo SC, Stieg PE, Boockvar JA, Ivanidze J, Moliterno JA, Parashar B, Trichter S, Sabbas AM, Nori D.

J Cancer Res Ther. 2010 Jan-Mar;6(1):65-74. doi: 10.4103/0973-1482.63547.

8.

Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases.

Rogers LR, Rock JP, Sills AK, Vogelbaum MA, Suh JH, Ellis TL, Stieber VW, Asher AL, Fraser RW, Billingsley JS, Lewis P, Schellingerhout D, Shaw EG; Brain Metastasis Study Group..

J Neurosurg. 2006 Sep;105(3):375-84.

PMID:
16961129
9.

Recurrent primary fibrosarcoma of the brain treated with the GliaSite brachytherapy system: case report.

Fraser RW, Limentani SA, Dollar JD, Asher A.

Surg Neurol. 2003 Dec;60(6):579-83; discussion 583-4.

PMID:
14670686
10.

Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.

Monroe JI, Dempsey JF, Dorton JA, Mutic S, Stubbs JB, Markman J, Williamson JF.

Med Phys. 2001 Jan;28(1):73-85.

PMID:
11213925
11.

Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.

Kleinberg L, Yoon G, Weingart JD, Parisi M, Olivi A, Detorie NA, Chan TA.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1385-91. doi: 10.1016/j.ijrobp.2008.12.074. Epub 2009 Apr 23.

PMID:
19394153
12.

GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.

Welsh J, Sanan A, Gabayan AJ, Green SB, Lustig R, Burri S, Kwong E, Stea B.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):159-65. Epub 2007 Feb 27.

PMID:
17331666
13.

Systemic iodine 125 activity after GliaSite brachytherapy: safety considerations.

Adkison JB, Thomadsen B, Howard SP.

Brachytherapy. 2008 Jan-Mar;7(1):43-6. doi: 10.1016/j.brachy.2007.11.001. Epub 2008 Jan 16.

PMID:
18201938
14.

Novel use of the Contura for high dose rate cranial brachytherapy.

Scanderbeg DJ, Alksne JF, Lawson JD, Murphy KT.

Med Dosim. 2011 Winter;36(4):344-6. doi: 10.1016/j.meddos.2010.08.001. Epub 2010 Dec 8.

PMID:
21144735
15.

Radiation safety considerations in GliaSite 125I brain implant procedures.

Strzelczyk J, Safadi R.

Health Phys. 2004 May;86(5 Suppl):S120-3.

PMID:
15069303
16.

Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite® Radiation Therapy System.

Chino K, Silvain D, Grace A, Stubbs J, Stea B.

Med Phys. 2008 Jul;35(7Part1):3383-3388. doi: 10.1118/1.2940602.

PMID:
28513009
17.

Cerebrovascular complications in cancer patients.

Rogers LR.

Neurol Clin. 2003 Feb;21(1):167-92. Review.

PMID:
12690649
18.

Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities.

Stubbs JB, Frankel RH, Schultz K, Crocker I, Dillehay D, Olson JJ.

J Neurosurg. 2002 Feb;96(2):335-43.

PMID:
11838809
19.

Radiation Safety Considerations In GliaSite 125I Brain Implant Procedures.

Strzelczyk J, Safadi R.

Health Phys. 2004 May;86 Suppl 2:S120-S123.

PMID:
28121704
20.

Supplemental Content

Support Center